Figure 2From: Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphoneAnalyses of dose linearity with OROS® hydromorphone: (A) Cmax/dose; (B) AUC0–48/dose. Dashed lines represent 95% CI.Back to article page